Fasting glucose or HbA1c — understanding which blood test is right for you is essential when assessing diabetes risk or confirming a diagnosis. Both tests measure how your body regulates blood sugar, but they work in fundamentally different ways and are suited to different clinical situations. Fasting plasma glucose captures a single snapshot of blood sugar after an overnight fast, whilst HbA1c reflects average glucose levels over the preceding two to three months. Knowing how each test is used, what your results mean, and which factors can affect their accuracy helps you make sense of your results and take the right next steps.

What Are Fasting Glucose and HbA1c Tests?

Fasting plasma glucose measures blood sugar after an eight-hour fast, whilst HbA1c reflects average glucose levels over two to three months by measuring glycated haemoglobin in red blood cells.

Fasting glucose and HbA1c are two distinct blood tests used to assess how the body regulates blood sugar (glucose). Both are central to the diagnosis and monitoring of diabetes mellitus and prediabetes, but they measure different aspects of glycaemic control and are used in different clinical contexts.

Fasting plasma glucose (FPG) measures the concentration of glucose in the blood after a period of at least eight hours without eating or drinking anything other than water. It provides a snapshot of blood sugar levels at a single point in time and reflects how well the body manages glucose in a fasted state. The test is typically performed in the morning and requires the patient to attend a clinic or laboratory having abstained from food overnight.

HbA1c (glycated haemoglobin) works quite differently. It measures the percentage of haemoglobin — the protein in red blood cells that carries oxygen — that has become chemically bonded to glucose over time. Because red blood cells have a lifespan of approximately 90 to 120 days, HbA1c reflects average blood glucose levels over the preceding two to three months. This makes it a valuable indicator of longer-term glycaemic control rather than a momentary reading.

Together, these tests give clinicians a more complete picture of a patient's glucose metabolism. Whilst fasting glucose can detect acute hyperglycaemia, HbA1c is particularly useful for identifying sustained elevations in blood sugar that may not always be apparent from a single fasting measurement.

It is important to note that HbA1c is not appropriate for diagnosing diabetes in certain groups, including children and young people, during pregnancy, when type 1 diabetes is suspected, or when hyperglycaemic symptoms have been present for fewer than two months. In these situations, fasting plasma glucose or an oral glucose tolerance test (OGTT) should be used instead. NICE recommends HbA1c for diagnosis and ongoing monitoring in appropriate adults; fasting plasma glucose is the preferred alternative diagnostic test when HbA1c is unsuitable (NICE NG28; WHO 2011).

How Each Test Is Used to Diagnose Diabetes in the UK

HbA1c is the preferred first-line diagnostic test for type 2 diabetes in most adults, but fasting plasma glucose is used when HbA1c is unreliable or clinically inappropriate, following NICE NG28 and WHO criteria.

In the UK, the diagnosis of diabetes and prediabetes follows guidance from NICE (NG28) and is aligned with World Health Organisation (WHO) criteria. Both fasting glucose and HbA1c are approved diagnostic tools, though they are not always interchangeable, and the choice of test depends on clinical circumstances.

HbA1c is the preferred first-line diagnostic test for type 2 diabetes in most adults presenting without symptoms, as it does not require fasting and can be performed at any time of day. It is also used to identify individuals at high risk of developing diabetes — a state referred to as non-diabetic hyperglycaemia (NDH) or prediabetes.

HbA1c should not be used for diagnosis in the following groups:

• Children and young people

• Pregnant women (an OGTT is used instead, per NICE NG3)

• Individuals with suspected type 1 diabetes

• Those whose hyperglycaemic symptoms have been present for fewer than two months

• Patients with conditions that affect red blood cell turnover or haemoglobin structure (see below)

Fasting plasma glucose is used when HbA1c is considered unreliable or inappropriate. Conditions that affect red blood cell turnover — such as haemolytic anaemia, haemoglobinopathies (e.g., sickle cell disease or thalassaemia), or recent blood transfusion — can falsely lower or raise HbA1c readings, making fasting glucose or OGTT the more accurate alternative in these patients.

Accepted diagnostic criteria in UK clinical practice include:

• Diabetes diagnosis: HbA1c ≥ 48 mmol/mol; or fasting plasma glucose ≥ 7.0 mmol/L; or random plasma glucose ≥ 11.1 mmol/L in the presence of symptoms; or 2-hour plasma glucose ≥ 11.1 mmol/L on OGTT

• Non-diabetic hyperglycaemia (prediabetes): HbA1c 42–47 mmol/mol; or fasting glucose 6.1–6.9 mmol/L (WHO impaired fasting glucose threshold)

In England, the NHS Diabetes Prevention Programme (NHS DPP) uses a broader eligibility threshold: fasting glucose 5.5–6.9 mmol/L or HbA1c 42–47 mmol/mol. Individuals meeting these criteria may be referred to the programme even if their fasting glucose falls below the WHO impaired fasting glucose cut-off of 6.1 mmol/L.

In asymptomatic individuals, NICE recommends that a single abnormal result should be confirmed by a repeat test on a separate day before a diagnosis of diabetes is made. However, in patients with classic symptoms of hyperglycaemia — such as polydipsia, polyuria, and unexplained weight loss — a single diagnostic result is sufficient.

Type 1 diabetes is typically diagnosed on clinical grounds (NICE NG17). Islet autoantibody and C-peptide testing are not routinely required at diagnosis; they should be considered when the type of diabetes is uncertain — for example, in adults where type 1 and type 2 diabetes are difficult to distinguish clinically.

Understanding Your Results: NHS Reference Ranges Explained

An HbA1c of 48 mmol/mol or above, or a fasting glucose of 7.0 mmol/L or above, indicates diabetes; results in the prediabetes range (HbA1c 42–47 mmol/mol or fasting glucose 6.1–6.9 mmol/L) require lifestyle intervention and monitoring.

Interpreting blood glucose results correctly is essential for both patients and clinicians. The NHS and NICE use standardised reference ranges to categorise results into normal, at-risk, and diabetic ranges, helping to guide appropriate clinical action.

HbA1c reference ranges:

• Below 42 mmol/mol: Normal — no evidence of diabetes or prediabetes

• 42–47 mmol/mol: Non-diabetic hyperglycaemia (prediabetes) — increased risk of developing type 2 diabetes; eligible for NHS DPP referral in England

• 48 mmol/mol or above: Indicative of diabetes (requires confirmation in asymptomatic individuals)

Fasting plasma glucose reference ranges:

• Below 5.5 mmol/L: Normal

• 5.5–6.0 mmol/L: Some NHS laboratories and the NHS DPP in England consider this range to indicate elevated risk; individuals may be eligible for referral to the NHS Diabetes Prevention Programme

• 6.1–6.9 mmol/L: Impaired fasting glucose (IFG) — a form of prediabetes as defined by WHO diagnostic criteria

• 7.0 mmol/L or above: Indicative of diabetes (requires confirmation in asymptomatic individuals)

For completeness, an oral glucose tolerance test (OGTT) may also be used. A 2-hour plasma glucose of 7.8–11.0 mmol/L indicates impaired glucose tolerance (IGT), whilst a result of 11.1 mmol/L or above is diagnostic of diabetes (subject to confirmation in asymptomatic individuals).

It is important to understand that these thresholds represent clinical cut-off points rather than absolute biological boundaries. Risk exists on a continuum, and individuals with results in the upper end of the normal range may still benefit from lifestyle advice and monitoring, particularly if they have other risk factors such as obesity, a family history of type 2 diabetes, or a history of gestational diabetes.

Results should always be interpreted in the context of the individual patient. For example, a slightly elevated HbA1c in a person with known haemoglobin variants may not accurately reflect their true glycaemic status. Similarly, acute illness, recent surgery, or significant physiological stress can temporarily raise fasting glucose levels, potentially leading to a misleading result. Your GP or practice nurse can help contextualise your results and advise on whether further testing is needed.

Factors That Can Affect the Accuracy of Each Test

Haemoglobinopathies, anaemia, and recent blood transfusion can falsely alter HbA1c, whilst inadequate fasting, acute illness, and certain medicines — including corticosteroids and antipsychotics — can raise fasting glucose readings.

Both fasting glucose and HbA1c are generally reliable tests, but a number of clinical and physiological factors can influence their accuracy. Being aware of these limitations helps ensure that results are interpreted appropriately and that the most suitable test is chosen for each individual.

Factors affecting HbA1c accuracy:

• Haemoglobinopathies (e.g., sickle cell trait, thalassaemia): These conditions alter red blood cell structure or lifespan, which can falsely lower or raise HbA1c values depending on the variant

• Haemolytic anaemia: Increased red blood cell destruction shortens the lifespan of haemoglobin, leading to a falsely low HbA1c

• Iron deficiency anaemia: Can falsely elevate HbA1c by prolonging red blood cell survival

• Recent iron or vitamin B12 therapy: Correction of deficiency anaemia can alter red blood cell turnover and affect HbA1c values

• Recent blood transfusion: Introduces donor red blood cells, diluting the patient's own glycated haemoglobin and lowering the result

• Advanced chronic kidney disease (CKD) or liver cirrhosis: Both conditions can affect red blood cell lifespan and HbA1c reliability

• Pregnancy: HbA1c is not recommended for diagnosing gestational diabetes; an OGTT is used instead (NICE NG3)

• Ethnicity: Some studies suggest HbA1c may slightly overestimate glycaemia in people of South Asian or African-Caribbean descent. However, no ethnicity-specific diagnostic thresholds are currently recommended in UK guidance; standard cut-offs apply to all adults

When HbA1c is unreliable due to any of the above, NICE recommends using fasting plasma glucose or an OGTT instead (NICE NG28).

Factors affecting fasting glucose accuracy:

• Inadequate fasting: Consuming food or caloric drinks within eight hours of the test will raise glucose levels and invalidate the result

• Acute physiological stress: Illness, infection, trauma, or surgery can cause transient hyperglycaemia unrelated to diabetes

• Certain medicines: Corticosteroids, antipsychotics, thiazide diuretics, some beta-blockers, and certain antiretroviral medicines (including some protease inhibitors) can raise fasting glucose levels

• Timing and sample handling: Delays in processing blood samples can cause glucose to be metabolised by red blood cells in the sample tube, lowering the measured concentration; fluoride oxalate tubes and prompt processing help minimise this

When there is uncertainty about which test to use, or when results appear inconsistent with the clinical picture, clinicians may request both tests or proceed to an OGTT for further clarification.

Next Steps After Abnormal Fasting Glucose or HbA1c Results

Prediabetes results prompt lifestyle advice and NHS Diabetes Prevention Programme referral, whilst diabetic-range results in asymptomatic individuals require a confirmatory repeat test before a formal diagnosis and treatment pathway are initiated.

Receiving an abnormal result can feel concerning, but it is important to remember that a single out-of-range value does not automatically confirm a diagnosis of diabetes. The appropriate next steps depend on the degree of abnormality, the presence or absence of symptoms, and the individual's overall clinical context.

If your result falls in the prediabetes range (HbA1c 42–47 mmol/mol or fasting glucose 5.5–6.9 mmol/L), your GP will typically:

• Provide structured lifestyle advice, including guidance on diet, physical activity, and weight management

• Refer you to the NHS Diabetes Prevention Programme (NHS DPP), a nationally commissioned behavioural intervention shown to reduce the risk of progression to type 2 diabetes

• Arrange repeat testing, usually annually, to monitor for any change in your glycaemic status

If your result is in the diabetic range (HbA1c ≥ 48 mmol/mol, fasting glucose ≥ 7.0 mmol/L, random plasma glucose ≥ 11.1 mmol/L with symptoms, or 2-hour OGTT glucose ≥ 11.1 mmol/L), and you are asymptomatic, a confirmatory repeat test on a separate day is required before a formal diagnosis is made. If confirmed, your GP will initiate a structured care pathway that may include:

• Further investigations (e.g., renal function, lipid profile, urine albumin-to-creatinine ratio, blood pressure assessment)

• Education and self-management support

• Referral to the NHS Diabetic Eye Screening Programme and arrangement of a foot health assessment

• Consideration of pharmacological treatment — most commonly metformin as first-line therapy in type 2 diabetes, initiated alongside lifestyle measures and based on HbA1c level and symptoms, in line with NICE NG28

• Referral to a diabetes specialist nurse or consultant diabetologist if indicated

• Advice regarding cardiovascular risk management and relevant immunisations (e.g., annual influenza vaccine)

If you are prescribed any medicine for diabetes and experience an unexpected reaction, you can report this to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

When to seek urgent medical help:

• Symptoms of hyperglycaemia such as excessive thirst, frequent urination, blurred vision, or unexplained weight loss — contact your GP promptly

• Symptoms suggestive of diabetic ketoacidosis (DKA) — including nausea, vomiting, abdominal pain, rapid breathing, or confusion — call 999 or go to A&E immediately

• Symptoms suggestive of hyperosmolar hyperglycaemic state (HHS), which can occur in older adults with type 2 diabetes and may present with severe dehydration, drowsiness, or confusion — call 999 or go to A&E immediately

Early identification and intervention remain the most effective strategies for preventing or delaying the complications of diabetes, including cardiovascular disease, neuropathy, retinopathy, and kidney disease. Regular monitoring and open communication with your healthcare team are key to managing your long-term health.

Frequently Asked Questions